Laure Guilhaudis

Dr. Laure Guilhaudis

CARMeN Institute, University of Rouen, Rouen, Normandie, France
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2004 in Peptides
Verified
Journal Article
Closed access
DCDavid Chatenet
David Chatenet
CDChristophe Dubessy
Christophe Dubessy
JLJérôme Leprince
Jérôme Leprince
CBCédric Boularan
Cédric Boularan
LCLudovic Carlier
Ludovic Carlier
HVHubert Vaudry
Hubert Vaudry

4 May 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SBSteve Bourgault
Steve Bourgault
David VaudryDavid Vaudry
David Vaudry
ISIsabelle Ségalas-Milazzo
Isabelle Ségalas-Milazzo
LGLaure Guilhaudis
Laure Guilhaudis
alain couvineaualain couvineau
alain couvineau
AFAlain Fournier
Alain Fournier

1 December 2012 in Peptides
Verified
Journal Article
Closed access
ARAline Rifflet
Aline Rifflet
SGSabine Gavalda
Sabine Gavalda
Nathan TENENathan TENE
Nathan TENE
JOJérôme Orivel
Jérôme Orivel
JLJérôme Leprince
Jérôme Leprince
MTMichel Treilhou
Michel Treilhou

1 July 2009 in Molecular Pharmacology
Verified
Journal Article
Open access
PDF file
EGEster Gutiérrez-Pascual
Ester Gutiérrez-Pascual
JLJérôme Leprince
Jérôme Leprince
AMAntonio J. Martínez-Fuentes
Antonio J. Martínez-Fuentes
ISIsabelle Ségalas-Milazzo
Isabelle Ségalas-Milazzo
RPRafael Pineda
Rafael Pineda
Justo CastañoJusto Castaño
Justo Castaño
Kisspeptins, the natural ligands of the G protein-coupled receptor KISS1R, comprise a family of related peptides derived from the proteolytic processing of a common precursor encoded by the KISS1 gene. Among those, Kisspeptin-10 (Kp-10) contains the basic residues to retain full functional activity and exhibits higher receptor affinity and biopotency than longer forms of the peptide. Although kisspeptins were first characterized by their ability to inhibit tumor metastasis, recent studies have revealed that the KISS1/KISS1R system plays an essential role in the neuroendocrine control of the reproductive axis. In this context, development and functional analysis of Kp-10 analogs may help in the search for new agonists and antagonists as valuable tools to manipulate the KISS1/KISS1R system and hence fertility. We report herein functional and structural analyses of a series of Ala-substituted rat kp-10 analogs, involving [Ca2+]i responses in rat kiss1r-transfected Chinese hamster ovary cells, dynamic luteinizing hormone (LH) responses in vivo, and NMR structural studies. In vitro assays revealed that Ala substitutions in positions 6 or 10 of kp-10 resulted in a significant increase in EC50 values (>6.46 × 10-6 M versus 1.54 to 2.6 × 10-8 M for rat and human Kp-10, respectively) and a substantial decrease in the proportion of responsive cells coupled to a marked increase in the time required to reach maximal response. In vivo assays showed that Ala6 substitution diminished and Ala10 substitution eliminated LH secretory responses, whereas coadministration of each analog failed to affect the LH-releasing ability of kp-10. Molecular modeling under NMR restraints revealed that kp-10 exhibits a helicoidal structure between the Asn4 and Tyr10 residues, with mixed α- and 310-helix characteristics. Ala6 substitution induced limited destabilization of the helix around the position of the substitution. Ala10 substitution was found to totally disrupt the helical structure in the C-terminal region of the molecule. Taken together, our results indicate that positions 6 and 10 are critical for kp-10 action at kiss1r and suggest that modifications in these positions could lead to the generation of new kisspeptin agonists and/or antagonists with altered functional and perhaps binding properties. Furthermore, they emphasize the importance of using combined, multidisciplinary approaches, including in vivo studies, to reliably evaluate structure function properties of novel kisspeptin analogs.

1 May 2016 in Peptides
Verified
Journal Article
Closed access
Nathan TENENathan TENE
Nathan TENE
EBElsa Bonnafé
Elsa Bonnafé
FBFanny Berger
Fanny Berger
ARAline Rifflet
Aline Rifflet
LGLaure Guilhaudis
Laure Guilhaudis
Michel TreilhouMichel Treilhou
Michel Treilhou

1 May 2008 in Peptides
Verified
Journal Article
Closed access
JLJérôme Leprince
Jérôme Leprince
DCDavid Chatenet
David Chatenet
CDChristophe Dubessy
Christophe Dubessy
AFAlain Fournier
Alain Fournier
BPBruno Pfeiffer
Bruno Pfeiffer
HVHubert Vaudry
Hubert Vaudry